Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Regeneron Pharmaceuticals, Inc. (REGN)

-NMS
316.22 5.96(1.85%) Jul 31, 4:00PM EDT
|After Hours : 320.97 Up 4.75 (1.50%) Jul 31, 7:27PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 424,362   750,269   (221,760)
Operating Activities, Cash Flows Provided By or Used In
Depreciation41,204  36,940  31,082  
Adjustments To Net Income308,751  (189,025)67,909  
Changes In Accounts Receivables(198,658)(590,085)(21,118)
Changes In Liabilities108,710  (30,098)9,687  
Changes In Inventories(47,956)(28,932)(14,094)
Changes In Other Operating Activities(52,765)(23,684)6,612  
Total Cash Flow From Operating Activities 583,648   (74,615) (141,682)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(156,323)(49,337)(57,217)
Investments(199,132)(31,184)185,965  
Other Cash flows from Investing Activities -  (552)(277)
Total Cash Flows From Investing Activities (355,455) (81,073) 128,471  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock57,393  63,549  137,387  
Net Borrowings(2,024)(2,203)389,440  
Other Cash Flows from Financing Activities(195,087)(163,300)(25,078)
Total Cash Flows From Financing Activities 77,139   (97,646) 384,249  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 305,332   (253,334) 371,038  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.